Salarius Pharmaceuticals's total assets for Q4 2024 were $3.02M, a decrease of -21.67% from the previous quarter. SLRX total liabilities were $1.51M for the fiscal quarter, a 61.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.